libtayo (cemiplimab) 350mg/7ml

How Libtayo Works

Libtayo is a medication used in the treatment of certain types of cancer, particularly advanced or metastatic cutaneous squamous cell carcinoma (CSCC) and advanced basal cell carcinoma (BCC). It belongs to a class of drugs known as checkpoint inhibitors. Libtayo works by targeting and blocking a protein called programmed death receptor-1 (PD-1) on certain immune cells, allowing the immune system to recognize and attack cancer cells more effectively. By enhancing the body’s immune response against cancer, Libtayo helps to slow down or stop the growth and spread of cancerous cells.

Side Effects of Libtayo

• Fatigue
• Nausea
• Diarrhea
• Decreased appetite
• Rash or itching
• Fever
• Cough
• Joint pain
• Weight loss

These side effects may vary in severity and may require medical attention depending on individual circumstances.

Indications for Libtayo

• Advanced or metastatic cutaneous squamous cell carcinoma (CSCC)
• Advanced basal cell carcinoma (BCC)

Contraindications for Libtayo

• Hypersensitivity to cemiplimab or any component of the formulation
• Active autoimmune disease that has required systemic treatment within the past 2 years
• Severe infections
• History of solid organ transplantation

— **

Price Comparison of Libtayo in Different Countries

**

Country	Price (per tablet)	Reference
Pakistan	PKR 50,000	medicalstore.com.pk Pakistan
United States	USD 2,500	Sanofi US
United Kingdom	GBP 1,800	Sanofi UK
Canada	CAD 3,000	Sanofi Canada
Australia	AUD 3,500	Sanofi Australia

 

Top 5 Global Brands of Cancer Immunotherapy Medications

1. Keytruda (Pembrolizumab)
2. Opdivo (Nivolumab)
3. Yervoy (Ipilimumab)
4. Libtayo (Cemiplimab)
5. Tecentriq (Atezolizumab)